Skip to main content
TipRanks
Go Ultimate75% OFF

Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh (A1LN34) Q2 2024 Earnings Report

BR:A1LN34 Q2 2024 EPS Results

Actual EPS
BRL 0.00
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
BRL 0.00

BR:A1LN34 Q2 2024 Revenue Results

Actual Revenue
BRL 3.44B
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+117.64%

Earnings Announcement Details

Quarter
Q2 2024
Date
08/01/2024
Time
Before Open
Conference Call
Thursday, August 1, 2024
BR:A1LN34 Upcoming Earnings

Alnylam Pharmaceuticals, Inc Shs Unsponsored Brazilian Depository Receipt Repr 0.05 Sh's next earnings date is estimated for February 18, 2027, based on past reporting schedules.

Q2 2024 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

BR:A1LN34 Earnings History

BR:A1LN34 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 18, 20272026 (Q4)―-0――
Oct 29, 20262026 (Q3)―0.000300.00% (+0.00)
Jul 30, 20262026 (Q2)―0.000―
Apr 30, 20262026 (Q1)―0.000―
Feb 12, 20262025 (Q4)―0.000―
Oct 30, 20252025 (Q3)―0.000―
Jul 31, 20252025 (Q2)―0.000―
May 01, 20252025 (Q1)―0.000―
Feb 13, 20252024 (Q4)―0.000―
Oct 31, 20242024 (Q3)―0.000―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed